Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 2, 2014
Pharmacy Choice - Pharmaceutical News - Pharma companies paid big bucks in Tennessee for bad drug deals [The Commercial Appeal, Memphis, Tenn.] - September 2, 2014

Pharmacy News Article

 10/21/12 - Pharma companies paid big bucks in Tennessee for bad drug deals [The Commercial Appeal, Memphis, Tenn.]

Oct. 21Schemes plotted behind closed doors. Government agents out to foil them. Inside sources spilling the beans. Bad guys brought to justice.

It's the plot of thousands of books, movies and television shows.

And it's a reality in Tennessee that has raked millions of dollars into the state coffers over the past few years. But it's not the high-flying, ticking-time-bomb stuff. Instead, preventing Medicaid fraud in pharmaceuticals is more often done with computers, health care claims data and spreadsheets.

Big pharmaceutical companies have paid out nearly $22 million to the state this year as part of multistate agreements to settle allegations that they broke the law.

In July, McKesson Corp. paid the state $2 million, the amount TennCare was deliberately overcharged by the company because it sold its drugs to the state at inflated prices.

GlaxoSmithKline the maker of Tums, Poligrip, Flonase and more paid Tennessee $13.5 million in a landmark $3 billion settlement that involved the federal government and several other states. The agreement settled claims that the company marketed numerous drugs for uses not approved by the government.

For example, it marketed the adult depression drug Paxil for children and adolescents and another depression drug, Wellbutrin, for weight loss and sexual dysfunction.

Whistleblowers are telling on their drug companies at higher rate, according to new figures from consumer advocate Public Citizen, in a trend that began in 2008. Most of them want to do the right thing, state officials said, but it also doesn't hurt that these company insiders get a percentage of the overall settlement, which can reach millions of dollars.

"There is more scrutiny now because every employee is a potential whistleblower," said Peter Coughlan, deputy of the Medicaid Fraud and Integrity Division in the Tennessee Attorney General's Office. "These companies have to remember that now every marketing manager, every sales person that's a potential plaintiff against them."

Coughlan's division was created 18 months ago and

now works with TennCare, the Office of Inspector General and the Tennessee Bureau of Investigation's Medicaid Fraud Control Unit in the TennCare provider Fraud Task Force. Together, the groups find health care fraud that rips off the taxpayer-funded TennCare program, recoups the money for the health insurance program and the rest of the funds go back to the state.

Should TennCare officials find an anomaly in some of their records, they hand it off to the TBI for further investigation. The agency has 20 Medicaid fraud investigators across the state with five in the Western Division, two of those in Memphis.

These agents must take further training in insurance claims data analysis. It's the inner-workings of government health insurance programs, including the galaxy of acronyms associated with it, said Norman Tidwell, special agent in charge of TBI's Medicaid Fraud Control Unit.

Tidwell said most crimes by pharmaceutical companies deal with either overpricing of off-label marketing like the McKesson and Glaxo-SmithKline cases this year, but said the circumstances are different each time.

"Some of it, historically, has been their (sales representatives) acting inappropriately and the company may or may not have had direct knowledge about it," Tidwell said. "Each situation has to stand on its own and we have to weigh those allegations when they come in to determine whether or not there has been a crime."

PhRMA, the pharmaceutical industry's advocacy group, said complying with federal rules is "critically important" for its industry.

"We believe that robust compliance programs will best ensure adherence to these standards and will serve the best interest of physicians and the patients they serve," said PhRMA spokesman Matthew Bennett. "Government enforcement efforts should be focused on those companies and individuals who knowingly and intentionally operate outside the law."

Tennessee's Coughlan and Tidwell agreed that more whistleblowers are making it harder for companies to carry out these schemes but that the fight against Medicaid fraud is far from over.

From 1991 to December 2010, Public Citizen reported financial settlements and court judgments from pharmaceutical companies of about $20 billion. In the past one-and-a-half years alone, the group reported 74 new settlements totaling $10.2 billion.

-

(c)2012 The Commercial Appeal (Memphis, Tenn.)

Visit The Commercial Appeal (Memphis, Tenn.) at www.commercialappeal.com

Distributed by MCT Information Services




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Sep 09: The Treatment of Depression and Anxiety in the Elderly
Sep 10: Comprehensive Asthma Care: Opportunities for Pharmacy Professionals
Sep 11: Legal & Practical Issues in Compounding Pharmacy
Sep 14: An Overview of Cancer Prevention & Management Strategies for Cancer Survivors
Sep 15: Vitamin D Guidelines: What You Need To Know
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415